Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

A longitudinal evaluation of a survivor-mentor program for child survivors of sex trafficking in the United States.

Rothman EF, Preis SR, Bright K, Paruk J, Bair-Merritt M, Farrell A.

Child Abuse Negl. 2019 Jul 27:104083. doi: 10.1016/j.chiabu.2019.104083. [Epub ahead of print]

PMID:
31358352
2.

Relationship of Cancer to Brain Aging Markers of Alzheimer's Disease: The Framingham Heart Study.

Gupta A, Preis SR, Beiser AS, Splansky GL, DeCarli CS, Au R, Driver JA.

Adv Geriatr Med Res. 2019;1. pii: e190006. doi: 10.20900/agmr20190006. Epub 2019 Jul 4.

3.

Evaluation of a Multi-Session Group Designed to Prevent Commercial Sexual Exploitation of Minors: The "My Life My Choice" Curriculum.

Rothman EF, Farrell A, Paruk J, Bright K, Bair-Merritt M, Preis SR.

J Interpers Violence. 2019 Jul 27:886260519865972. doi: 10.1177/0886260519865972. [Epub ahead of print]

PMID:
31354019
4.

Distribution of cerebral microbleeds in the East and West: Individual participant meta-analysis.

Yakushiji Y, Wilson D, Ambler G, Charidimou A, Beiser A, van Buchem MA, DeCarli C, Ding D, Gudnason V, Hara H, Imaizumi T, Kohara K, Kwon HM, Launer LJ, Mok V, Phan T, Preis SR, Romero JR, Seshadri S, Srikanth V, Takashima Y, Tsushima Y, Wang Z, Wolf PA, Xiong Y, Yamaguchi S, Werring DJ.

Neurology. 2019 Mar 5;92(10):e1086-e1097. doi: 10.1212/WNL.0000000000007039. Epub 2019 Feb 1. Erratum in: Neurology. 2019 Jul 2;93(1):46.

PMID:
30709966
5.

Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.

Staerk L, Wang B, Preis SR, Larson MG, Lubitz SA, Ellinor PT, McManus DD, Ko D, Weng LC, Lunetta KL, Frost L, Benjamin EJ, Trinquart L.

BMJ. 2018 Apr 26;361:k1453. doi: 10.1136/bmj.k1453.

6.

Relation of Orthostatic Hypotension With New-Onset Atrial Fibrillation (From the Framingham Heart Study).

Ko D, Preis SR, Lubitz SA, McManus DD, Vasan RS, Hamburg NM, Benjamin EJ, Mitchell GF.

Am J Cardiol. 2018 Mar 1;121(5):596-601. doi: 10.1016/j.amjcard.2017.11.036. Epub 2017 Dec 11.

7.

Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.

Weinstein G, Zelber-Sagi S, Preis SR, Beiser AS, DeCarli C, Speliotes EK, Satizabal CL, Vasan RS, Seshadri S.

JAMA Neurol. 2018 Jan 1;75(1):97-104. doi: 10.1001/jamaneurol.2017.3229.

8.

Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation.

Weng LC, Preis SR, Hulme OL, Larson MG, Choi SH, Wang B, Trinquart L, McManus DD, Staerk L, Lin H, Lunetta KL, Ellinor PT, Benjamin EJ, Lubitz SA.

Circulation. 2018 Mar 6;137(10):1027-1038. doi: 10.1161/CIRCULATIONAHA.117.031431. Epub 2017 Nov 12.

9.

Baseline White Matter Hyperintensities and Hippocampal Volume are Associated With Conversion From Normal Cognition to Mild Cognitive Impairment in the Framingham Offspring Study.

Bangen KJ, Preis SR, Delano-Wood L, Wolf PA, Libon DJ, Bondi MW, Au R, DeCarli C, Brickman AM.

Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):50-56. doi: 10.1097/WAD.0000000000000215.

10.

Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study.

Chouraki V, Preis SR, Yang Q, Beiser A, Li S, Larson MG, Weinstein G, Wang TJ, Gerszten RE, Vasan RS, Seshadri S.

Alzheimers Dement. 2017 Dec;13(12):1327-1336. doi: 10.1016/j.jalz.2017.04.009. Epub 2017 Jun 8.

11.

Clinical and Environmental Correlates of Serum BDNF: A Descriptive Study with Plausible Implications for AD Research.

Weinstein G, Preis SR, Beiser AS, Kaess B, Chen TC, Satizabal C, Rahman F, Benjamin EJ, Vasan RS, Seshadri S.

Curr Alzheimer Res. 2017;14(7):722-730. doi: 10.2174/1567205014666170203094520.

12.

Cerebral Microbleeds as Predictors of Mortality: The Framingham Heart Study.

Romero JR, Preis SR, Beiser A, Himali JJ, Shoamanesh A, Wolf PA, Kase CS, Vasan RS, DeCarli C, Seshadri S.

Stroke. 2017 Mar;48(3):781-783. doi: 10.1161/STROKEAHA.116.015354. Epub 2017 Jan 31. Erratum in: Stroke. 2017 Mar;48(3):e98.

13.

Neuropsychological Criteria for Mild Cognitive Impairment and Dementia Risk in the Framingham Heart Study.

Jak AJ, Preis SR, Beiser AS, Seshadri S, Wolf PA, Bondi MW, Au R.

J Int Neuropsychol Soc. 2016 Oct;22(9):937-943. Epub 2016 Mar 31.

14.

Circulating biomarkers and incident ischemic stroke in the Framingham Offspring Study.

Shoamanesh A, Preis SR, Beiser AS, Kase CS, Wolf PA, Vasan RS, Benjamin EJ, Seshadri S, Romero JR.

Neurology. 2016 Sep 20;87(12):1206-11. doi: 10.1212/WNL.0000000000003115. Epub 2016 Aug 24.

15.

Pulse Pressure Is Associated With Early Brain Atrophy and Cognitive Decline: Modifying Effects of APOE-ε4.

Nation DA, Preis SR, Beiser A, Bangen KJ, Delano-Wood L, Lamar M, Libon DJ, Seshadri S, Wolf PA, Au R.

Alzheimer Dis Assoc Disord. 2016 Jul-Sep;30(3):210-5. doi: 10.1097/WAD.0000000000000127.

16.

Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke.

Weinstein G, Beiser AS, Preis SR, Courchesne P, Chouraki V, Levy D, Seshadri S.

Alzheimers Dement (Amst). 2016 Jul 9;3:103-9. doi: 10.1016/j.dadm.2016.06.005. eCollection 2016.

17.

Association between atrial fibrillation and volumetric magnetic resonance imaging brain measures: Framingham Offspring Study.

Piers RJ, Nishtala A, Preis SR, DeCarli C, Wolf PA, Benjamin EJ, Au R.

Heart Rhythm. 2016 Oct;13(10):2020-4. doi: 10.1016/j.hrthm.2016.07.004. Epub 2016 Jul 11.

18.

Population Normative Data for the CERAD Word List and Victoria Stroop Test in Younger- and Middle-Aged Adults: Cross-Sectional Analyses from the Framingham Heart Study.

Hankee LD, Preis SR, Piers RJ, Beiser AS, Devine SA, Liu Y, Seshadri S, Wolf PA, Au R.

Exp Aging Res. 2016 Jul-Sep;42(4):315-28. doi: 10.1080/0361073X.2016.1191838.

19.

Circulating vascular endothelial growth factor and the risk of cardiovascular events.

Kaess BM, Preis SR, Beiser A, Sawyer DB, Chen TC, Seshadri S, Vasan RS.

Heart. 2016 Dec 1;102(23):1898-1901. doi: 10.1136/heartjnl-2015-309155. Epub 2016 Jun 27.

PMID:
27354275
20.

Neck Circumference, Brain Imaging Measures, and Neuropsychological Testing Measures.

Therkelsen KE, Preis SR, Beiser A, DeCarli C, Seshadri S, Wolf P, Au R, Fox CS.

J Stroke Cerebrovasc Dis. 2016 Jul;25(7):1570-1581. doi: 10.1016/j.jstrokecerebrovasdis.2016.02.016. Epub 2016 Apr 4.

PMID:
27056441
21.

Carotid Atherosclerosis and Cerebral Microbleeds: The Framingham Heart Study.

Romero JR, Preis SR, Beiser A, DeCarli C, D'Agostino RB, Wolf PA, Vasan RS, Polak JF, Seshadri S.

J Am Heart Assoc. 2016 Mar 18;5(3):e002377. doi: 10.1161/JAHA.115.002377.

22.

Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke.

Andersson C, Preis SR, Beiser A, DeCarli C, Wollert KC, Wang TJ, Januzzi JL Jr, Vasan RS, Seshadri S.

Stroke. 2015 Sep;46(9):2568-75. doi: 10.1161/STROKEAHA.115.009026. Epub 2015 Jul 28.

23.

Long-term exposure to fine particulate matter, residential proximity to major roads and measures of brain structure.

Wilker EH, Preis SR, Beiser AS, Wolf PA, Au R, Kloog I, Li W, Schwartz J, Koutrakis P, DeCarli C, Seshadri S, Mittleman MA.

Stroke. 2015 May;46(5):1161-6. doi: 10.1161/STROKEAHA.114.008348.

24.

Verbal memory and brain aging: an exploratory analysis of the role of error responses in the Framingham Study.

Libon DJ, Preis SR, Beiser AS, Devine S, Seshadri S, Wolf PA, DeCarli C, Au R.

Am J Alzheimers Dis Other Demen. 2015 Sep;30(6):622-8. doi: 10.1177/1533317515577184. Epub 2015 Mar 18.

25.

Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community.

Kaess BM, Preis SR, Lieb W, Beiser AS, Yang Q, Chen TC, Hengstenberg C, Erdmann J, Schunkert H, Seshadri S, Vasan RS; CARDIoGRAM, Assimes TL, Deloukas P, Holm H, Kathiresan S, König IR, McPherson R, Reilly MP, Roberts R, Samani NJ, Stewart AF.

J Am Heart Assoc. 2015 Mar 11;4(3):e001544. doi: 10.1161/JAHA.114.001544. Erratum in: J Am Heart Assoc. 2016 Jul;5(7). pii: e002098. doi: 10.1161/JAHA.116.002098.

26.

Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study.

Shoamanesh A, Preis SR, Beiser AS, Vasan RS, Benjamin EJ, Kase CS, Wolf PA, DeCarli C, Romero JR, Seshadri S.

Neurology. 2015 Feb 24;84(8):825-32. doi: 10.1212/WNL.0000000000001279. Epub 2015 Jan 28.

27.

Cognitive performance after stroke--the Framingham Heart Study.

Weinstein G, Preis SR, Beiser AS, Au R, Kelly-Hayes M, Kase CS, Wolf PA, Seshadri S.

Int J Stroke. 2014 Oct;9 Suppl A100:48-54. doi: 10.1111/ijs.12275. Epub 2014 Apr 30.

28.

Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.

Chouraki V, Beiser A, Younkin L, Preis SR, Weinstein G, Hansson O, Skoog I, Lambert JC, Au R, Launer L, Wolf PA, Younkin S, Seshadri S.

Alzheimers Dement. 2015 Mar;11(3):249-57.e1. doi: 10.1016/j.jalz.2014.07.001. Epub 2014 Sep 10.

29.

Mid-life Cardiovascular Risk Impacts Memory Function: The Framingham Offspring Study.

Gupta A, Preis SR, Beiser A, Devine S, Hankee L, Seshadri S, Wolf PA, Au R.

Alzheimer Dis Assoc Disord. 2015 Apr-Jun;29(2):117-23. doi: 10.1097/WAD.0000000000000059.

30.

Mid-adulthood risk factor profiles for CKD.

McMahon GM, Preis SR, Hwang SJ, Fox CS.

J Am Soc Nephrol. 2014 Nov;25(11):2633-41. doi: 10.1681/ASN.2013070750. Epub 2014 Jun 26.

31.

Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study.

Romero JR, Preis SR, Beiser A, DeCarli C, Viswanathan A, Martinez-Ramirez S, Kase CS, Wolf PA, Seshadri S.

Stroke. 2014 May;45(5):1492-4. doi: 10.1161/STROKEAHA.114.004130. Epub 2014 Apr 8.

32.

Development and validation of a brief dementia screening indicator for primary care.

Barnes DE, Beiser AS, Lee A, Langa KM, Koyama A, Preis SR, Neuhaus J, McCammon RJ, Yaffe K, Seshadri S, Haan MN, Weir DR.

Alzheimers Dement. 2014 Nov;10(6):656-665.e1. doi: 10.1016/j.jalz.2013.11.006. Epub 2014 Feb 1.

33.

Gender and incidence of dementia in the Framingham Heart Study from mid-adult life.

Chêne G, Beiser A, Au R, Preis SR, Wolf PA, Dufouil C, Seshadri S.

Alzheimers Dement. 2015 Mar;11(3):310-320. doi: 10.1016/j.jalz.2013.10.005. Epub 2014 Jan 10.

34.

Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study.

Weinstein G, Beiser AS, Choi SH, Preis SR, Chen TC, Vorgas D, Au R, Pikula A, Wolf PA, DeStefano AL, Vasan RS, Seshadri S.

JAMA Neurol. 2014 Jan;71(1):55-61. doi: 10.1001/jamaneurol.2013.4781.

35.

Qualitative neuropsychological measures: normative data on executive functioning tests from the Framingham offspring study.

Hankee LD, Preis SR, Beiser AS, Devine SA, Liu Y, Seshadri S, Wolf PA, Au R.

Exp Aging Res. 2013;39(5):515-35. doi: 10.1080/0361073X.2013.839029.

36.

Midlife cardiovascular risk impacts executive function: Framingham offspring study.

Nishtala A, Preis SR, Beiser A, Devine S, Hankee L, Seshadri S, Wolf PA, Au R.

Alzheimer Dis Assoc Disord. 2014 Jan-Mar;28(1):16-22. doi: 10.1097/WAD.0b013e3182a715bc.

37.

Serum brain-derived neurotrophic factor and vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury: Framingham Study.

Pikula A, Beiser AS, Chen TC, Preis SR, Vorgias D, DeCarli C, Au R, Kelly-Hayes M, Kase CS, Wolf PA, Vasan RS, Seshadri S.

Stroke. 2013 Oct;44(10):2768-75. doi: 10.1161/STROKEAHA.113.001447. Epub 2013 Aug 8.

38.

Early-adulthood cardiovascular disease risk factor profiles among individuals with and without diabetes in the Framingham Heart Study.

Preis SR, Pencina MJ, Mann DM, D'Agostino RB Sr, Savage PJ, Fox CS.

Diabetes Care. 2013 Jun;36(6):1590-6. doi: 10.2337/dc12-1121. Epub 2013 Jan 22.

39.

Neck circumference and the development of cardiovascular disease risk factors in the Framingham Heart Study.

Preis SR, Pencina MJ, D'Agostino RB Sr, Meigs JB, Vasan RS, Fox CS.

Diabetes Care. 2013 Jan;36(1):e3. doi: 10.2337/dc12-0738. No abstract available.

40.

Relations of long-term and contemporary lipid levels and lipid genetic risk scores with coronary artery calcium in the framingham heart study.

Tsao CW, Preis SR, Peloso GM, Hwang SJ, Kathiresan S, Fox CS, Cupples LA, Hoffmann U, O'Donnell CJ.

J Am Coll Cardiol. 2012 Dec 11;60(23):2364-71. doi: 10.1016/j.jacc.2012.09.007. Epub 2012 Nov 7.

41.

Lipoprotein phospholipase A2 and cerebral microbleeds in the Framingham Heart Study.

Romero JR, Preis SR, Beiser AS, DeCarli C, Lee DY, Viswanathan A, Benjamin EJ, Fontes J, Au R, Pikula A, Wang J, Kase CS, Wolf PA, Irrizary MC, Seshadri S.

Stroke. 2012 Nov;43(11):3091-4. doi: 10.1161/STROKEAHA.112.656744. Epub 2012 Sep 6.

42.

Genetic variability of smoking persistence in African Americans.

Hamidovic A, Kasberger JL, Young TR, Goodloe RJ, Redline S, Buxbaum SG, Benowitz NL, Bergen AW, Butler KR, Franceschini N, Gharib SA, Hitsman B, Levy D, Meng Y, Papanicolaou GJ, Preis SR, Spring B, Styn MA, Tong EK, White WB, Wiggins KL, Jorgenson E.

Cancer Prev Res (Phila). 2011 May;4(5):729-34. doi: 10.1158/1940-6207.CAPR-10-0362. Epub 2011 Mar 24.

43.

Application of a repeat-measure biomarker measurement error model to 2 validation studies: examination of the effect of within-person variation in biomarker measurements.

Preis SR, Spiegelman D, Zhao BB, Moshfegh A, Baer DJ, Willett WC.

Am J Epidemiol. 2011 Mar 15;173(6):683-94. doi: 10.1093/aje/kwq415. Epub 2011 Feb 22.

44.

Dietary protein and risk of ischemic heart disease in middle-aged men.

Preis SR, Stampfer MJ, Spiegelman D, Willett WC, Rimm EB.

Am J Clin Nutr. 2010 Nov;92(5):1265-72. doi: 10.3945/ajcn.2010.29626. Epub 2010 Sep 29.

45.

Health insurance and cardiovascular disease risk factors.

Brooks EL, Preis SR, Hwang SJ, Murabito JM, Benjamin EJ, Kelly-Hayes M, Sorlie P, Levy D.

Am J Med. 2010 Aug;123(8):741-7. doi: 10.1016/j.amjmed.2010.02.013.

46.

Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study.

Preis SR, Massaro JM, Hoffmann U, D'Agostino RB Sr, Levy D, Robins SJ, Meigs JB, Vasan RS, O'Donnell CJ, Fox CS.

J Clin Endocrinol Metab. 2010 Aug;95(8):3701-10. doi: 10.1210/jc.2009-1779. Epub 2010 May 19.

47.

Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study.

Preis SR, Massaro JM, Robins SJ, Hoffmann U, Vasan RS, Irlbeck T, Meigs JB, Sutherland P, D'Agostino RB Sr, O'Donnell CJ, Fox CS.

Obesity (Silver Spring). 2010 Nov;18(11):2191-8. doi: 10.1038/oby.2010.59. Epub 2010 Mar 25.

48.

Lack of association between dietary protein intake and risk of stroke among middle-aged men.

Preis SR, Stampfer MJ, Spiegelman D, Willett WC, Rimm EB.

Am J Clin Nutr. 2010 Jan;91(1):39-45. doi: 10.3945/ajcn.2009.28060. Epub 2009 Nov 4.

49.

Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study.

Preis SR, Pencina MJ, Hwang SJ, D'Agostino RB Sr, Savage PJ, Levy D, Fox CS.

Circulation. 2009 Jul 21;120(3):212-20. doi: 10.1161/CIRCULATIONAHA.108.846519. Epub 2009 Jul 6.

50.

Eligibility of individuals with subclinical coronary artery calcium and intermediate coronary heart disease risk for reclassification (from the Framingham Heart Study).

Preis SR, Hwang SJ, Fox CS, Massaro JM, Levy D, Hoffmann U, O'Donnell CJ.

Am J Cardiol. 2009 Jun 15;103(12):1710-5. doi: 10.1016/j.amjcard.2009.02.020. Epub 2009 May 3.

Supplemental Content

Loading ...
Support Center